News

Mar 12, 2018
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation

COPENHAGEN, Denmark— 12 March 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...

Read More
Mar 8, 2018
Vectorious closes B round, setting stage for trials of heart-monitoring implant

Vectorious Medical Technologies has raised cash to trial an implant for monitoring left atrial pressure...

Read More
Feb 8, 2018
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation

COPENHAGEN, Denmark— 8 February 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...

Read More
Jan 29, 2018
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results

ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC Houston, TX, USA, January...

Read More
Nov 21, 2017
480 Biomedical’s Novel Technology Featured in Nature Materials

480 Biomedical develops new technology which imparts metal-like strength on bioresorbable polymers WATERTOWN, Mass., Nov. 21,...

Read More
Oct 10, 2017
Boston Scientific Announces Agreement to Acquire Apama Medical

Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments...

Read More